Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy by Garzón, Ingrid et al.
Original Article
Evaluation of the Cell Viability of Human Wharton’s
Jelly Stem Cells for Use in Cell Therapy
Ingrid Garzo´n, D.D.S., Ph.D.,1 Barbara Pe´rez-Ko¨hler, B.Sc.,2 Juan Garrido-Go´mez, M.D., Ph.D.,3
Victor Carriel, M.D., Ph.D.,1 Renato Nieto-Aguilar, D.D.S., Ph.D.,1 Miguel Angel Martı´n-Piedra, D.D.S.,1
Natalio Garcı´a-Honduvilla, B.Sc., Ph.D.,2 Julia Buja´n, B.Sc., M.D., Ph.D.,2
Antonio Campos, M.D., Ph.D.,1 and Miguel Alaminos, M.D., Ph.D., B.Sc., Ph.D.1
Human umbilical cord Wharton’s jelly stem cells (HWJSCs) are gaining attention as a possible clinical source of
mesenchymal stem cells for cell therapy and tissue engineering due to their high accessibility, expansion po-
tential, and plasticity. We employed a combination of highly sensitive techniques to determine the average cell
viability levels and proliferation capabilities of 10 consecutive cell passages of cultured HWJSCs and then used
RNA microarrays to identify genes associated with changes in cell viability levels. We found an initial decrease
in cell viability from the first to the third cell passage followed by an increase until the sixth passage and a final
decrease from the sixth to tenth cell passages. The highest cell viability levels corresponded to the fifth and sixth
passages. The intracellular ionic contents of potassium, sodium, and chlorine suggest that the lower cell viability
levels at passages 2, 3, and 8–10 may be associated with apoptotic cell death. In fact, gene expression analysis
revealed that the average cell viability was significantly associated with genes with a function in apoptotic cell
death, especially pro-apoptotic FASTKD2, BNIP3L genes and anti-apoptotic TNFAIP8 and BCL2L2 genes. This
correlation with both pro-apoptotic and anti-apoptotic genes suggests that there may be a complex live-death
equilibrium in cultured HWJSCs kept in culture for multiple cell passages. In this study, the highest cell viability
levels corresponded to the fifth and sixth HWJSC passages, suggesting that these passages should be prefer-
entially employed in cell therapy or tissue engineering protocols using this cell type.
Introduction
The umbilical cord is a major source of nonembryonicstem cells with high proliferation and differentiation
capabilities.1–3 Among these, mesenchymal stem cells (MSCs)
can be isolated for culture from umbilical cord blood4 or from
Wharton’s jelly. Human Wharton’s jelly stem cells (HWJSCs)
are considered to have an elevated differentiation potential5
and telomerase activity6 and a low expression of class I and II
major histocompatibility complex antigens,7,3 making them
excellent candidate cells for the generation of artificial tissues
by tissue engineering and for use in cell therapy protocols.
Various in vivo studies have examined the usefulness of
HWJSC to treat different diseases,5,8 but the results have
been controversial. One possibility is that the stem cells used
in some of these studies did not have adequate cell viability
levels, which are not usually measured by authors using
highly sensitive methods. Only viable cells are suitable for
clinical or research utilization, and the effectiveness of most
cell therapy and tissue engineering protocols is strongly de-
pendent on the availability of an adequate source of viable
and functional cells.9,10 One of the key factors in the viability
of cultured cells is the cell passage at which they are clini-
cally utilized; thus, some cell cultures established from
newborn tissues tend to show a slow proliferation rate be-
yond the fifth passage.11 However, the cell viability of
HWJSCs kept in culture has not been determined to date,
and sequential changes that may take place in consecutive
cell passages are poorly understood.
Various methods have been used to determine the via-
bility of different cultured cell types. They include techniques
that determine permeability alterations in the cell membrane
by using trypan blue or other vital dyes,12 but these are not
sufficiently accurate to detect and predict early cell damage,
only identifying cell alterations once they have become ir-
reversible. One of the most sensitive and accurate viability
assays uses electron-probe X-ray microanalysis to quantify
the intracellular contents of the major cell elements, espe-
cially potassium (K), sodium (Na), and chlorine (Cl).13–16
This highly sensitive technique also allows the simultaneous
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analysis of the intracellular ionic concentrations and ultra-
structure of the cells.15,17,18 The use of this method has per-
mitted accurate measurement of the intracellular ionic
composition of several cell types, including U937,19 MCF720
and K56218 cell lines, and primary cell cultures of human oral
mucosa keratinocytes,21 umbilical cord endothelial cells,10
and rabbit cornea endothelial cells.9
The recent development of microarray techniques that
quantify the expression levels of thousands of genes in a
single experiment allows cell viability to be evaluated from a
genetic standpoint. Specific cell properties, including toxic
stress response and cell viability, can be quantified by using
microarrays to measure gene expression levels.22–26
With this background, the aim of this study was to iden-
tify the most viable subcultures of HWJSC for use in cell
therapy and tissue engineering by means of classical and
highly sensitive methods.
Materials and Methods
Isolation and culture of HWJSC
Human umbilical cords were obtained from full-term
newborns delivered by cesarean section (n = 10). After de-
livery, the umbilical cords were handled under sterile con-
ditions in a tissue bank. Arteries and veins were surgically
removed to prevent red blood cell contamination, and small
explants of Wharton’s jelly were obtained. These explants
were then digested in type I collagenase (Gibco BRL
Life Technologies) and trypsin 0.5 g/L-ethylenediaminete-
traacetic acid (EDTA) 0.2 g/L solution (Gibco BRL) for iso-
lation of the stromal cells. Once isolated, HWJSCs were
cultured in 75 cm2 culture flasks in Amniomax culture
medium (Gibco BRL) as previously described.1 Cell cultures
were maintained at 37C in a humidified incubator with a 5%
CO2 atmosphere. The culture medium was changed once
every 3 days, and cell growth was monitored every 12 h by
ocular inspection using a phase-contrast light microscope.
Once the cells reached subconfluence (42,000– 13,500 cells
per cm2), cell cultures were trypsinized using trypsin 0.5 g/
L-EDTA 0.2 g/L solution at 37C for 8 min. The number of
days between consecutive passages depended on the time
taken by the cells to reach subconfluence (mean 5.8 – 2.6 days
between passages), plating subcultured cells in new flasks at
a density of 13,333 cells per cm2 (1,000,000 cells per flask of
75 cm2 of surface). We used identical conditions (culture
plates, culture medium, and cell incubator) for all subcul-
tures. The cells were kept in culture for ten consecutive
passages (P1 to P10).
Ethical approval for this experimental protocol was
granted by the Institutional Ethical and Research Review
Board. Parents or guardians of all newborns provided writ-
ten consent for their inclusion in this study.
Cell proliferation analysis
First, cell proliferation was assessed by means of a highly
sensitive Real-Time Cell Analyzer (RTCA; XCELLigence,
Roche Applied Science). This analyzer uses sensor electrodes
that measure the electronic impedance of cultured cells,
yielding the Cell Index (unit-less parameter) to measure the
relative change in electrical impedance and represent the cell
status. The Cell Index is calculated by dividing the imped-
ance change by a background value and is dependent on the
number of cultured cells, because the impedance increases
with more cells on the electrodes. In our assays, 30,000
HWJSCs per cm2 were cultured on 96-well plates with at-
tached microelectrodes and analyzed for 100 h. All determi-
nations were carried out using duplicates. Data were
analyzed using XCELLigence software.
Cell proliferation and viability were then measured by
using the water-soluble tetrazolium salt-1 (WST-1) colori-
metric assay on 10 consecutive cell passages of HWJSC (Cell
Proliferation Reagent WST-1, Roche Diagnostics). WST-1 is a
tetrazolium dye containing an electron coupling reagent that
is cleaved by the mitochondrial dehydrogenase enzyme to a
formazan dye. The reaction directly correlates with the
number of metabolically active proliferating cells and can
serve as a marker of cell viability and cell proliferation. For
this analysis, 20,000 cells were seeded per well in a 96-well
plate with 100 mL of culture medium. After 24 h, the medium
was replaced with fresh medium containing 1/10 volume of
cell proliferation reagent WST-1 and incubated for 4 h at
37C before the absorbance at 450 nm was quantified in a
spectrophotometer. Cells incubated for 15 min in 1% triton-X
were used as controls. The data presented are from five
separate experiments.
Cell viability analysis
The percentage of live and dead cells in each cell passage
was determined by means of the trypan blue dye exclusion
test. Briefly, each subconfluent cell culture was trypsinized
with trypsin 0.5 g/L-EDTA 0.2 g/L solution for 8 min at
37C, and the detached cells were harvested by centrifuga-
tion and resuspended in 1 mL of culture medium. Then,
100 mL of the cell suspension were mixed with 0.4% trypan
blue solution (Sigma-Aldrich ref. T8154) and incubated for
5 min. at room temperature. Finally, we quantified the
number of white and blue cells by using a Neubauer
chamber in a Nikon Eclipse 90i light microscope to count a
minimum of 200 cells per cell passage, enabling calculation
of the percentage of live and dead cells. All cell counts were
done in quadruplicate, and median values and means (with
standard deviations) were calculated for each cell passage.
For the LIVE/DEAD Cell Viability Assay in each cell
passage, 10,000 HWJSCs were cultured on chamber slides
(Lab-Tek Chamber Slides, Nunc) and allowed to attach to the
bottom for 24 h. Then, cells were washed twice with PBS and
stained with the LIVE/DEAD assay reagents (calcein/AM
and ethidium homodimer-1; Invitrogen) following the pro-
tocols supplied by Invitrogen. Finally, the number of live
(green) and dead (red) cells was determined by using a
fluorescence microscope. These experiments were carried out
in quadruplicate, and the mean percentage of live cells was
calculated for each cell passage.
For electron-probe X-ray microanalysis, subconfluent
HWJSCs were subcultured using trypsin-EDTA on plated
gold grids coated with a thin layer of Pioloform (polyvinyl
butyral) (Ted Pella, Inc.) following previously published
methods.9,21,27 Cells were seeded at a density of 5000 cells
per grid and cultured in Amniomax medium. After 24 h of
culture on the Pioloform-coated gold grids, support grids
containing the HWJSCs were washed in ice-cold distilled
water for 5 s to remove the extracellular medium. After
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washing, excess water was drained from the surface, and the
grids were immediately plunge-frozen in liquid nitrogen.18
After cryofixation, the grids were placed in a precooled
aluminum specimen holder at liquid nitrogen temperature
and freeze dried at increasing temperatures for 24 h in an
E5300 Polaron freezer-drier apparatus equipped with a
vacuum rotatory pump system. Freeze-dried gold grids were
carbon coated in a high-vacuum coating system and micro-
analyzed within 6 h. Electron probe X-ray microanalysis of
the specimens was performed with a Philips XL30 scanning
electron microscope (SEM) equipped with an EDAX DX-4
microanalytical system and a solid-state backscattered elec-
tron (BSE) detector. The samples were examined by SEM
with a combination of secondary electron and BSE imaging
modes. For X-ray microanalysis, the analytical conditions
were tilt angle 08, take-off angle 61.348, and working dis-
tance 10 mm. The acceleration voltage was 10 kV. All spectra
were collected in the spot mode at 10,000 · (equivalent to
50 nm spot diameter) for 200 s live time, and the number of
counts per second recorded by the detector was around 500.
All determinations were performed on the central area of the
cell nucleus. To determine total ion content, we used the
peak-to-local-background ratio method28 with reference to
standards composed of 20% dextran containing known
amounts of inorganic salts.29 In this study, we analyzed the
ionic content of 25 HWJSCs corresponding to each cell pas-
sage (P1 to P10) using cells from four different umbilical
cords. Controls were human fibroblasts isolated from oral
mucosa biopsies (highly viable cells) and the same cells
treated with 10 mM HEMA, a known inductor of cell apo-
ptosis30 (cells with low viability levels).
Flow cytometry
To evaluate the expression of key MSC markers on the
different HWJSC cultures used in this study, cells corre-
sponding to passages P1, P3, P6, and P9 were analyzed using
anti-CD90-Allophycocyanin conjugated (CD90-APC) and
anti-CD45-Phycoerythrin conjugated (CD45-PE) antibodies
(R & D Systems, Inc.). Samples containing 0.5 · 106 cells were
placed in flow cytometry tubes, washed with 2 mL of staining
buffer (R & D Systems, Inc.), and Fc receptors were then
blocked by incubating the cells for 5 min with 2 mL of PBS 1·
containing 0.1% BSA and 0.1% FBS. Next, cells were stained
with the antibodies and isotype controls in different tubes and
incubated for 45 min at 4C in darkness. Cells were washed
with 2 mL of staining buffer, and samples were immediately
acquired on an FACS CALIBUR Flow Cytometer.
Multilineage cell differentiation analysis
The multilineage differentiation potential of isolated
HWJSCs was confirmed by subculturing primary HWJSC
cultures on chamber slides and inducing differentiation to
osteogenic, chondrogenic, and adipogenic cell lineages by
using specific conditioning media as previously described.31
Then, cell differentiation was assessed by cytochemical his-
tological staining, staining samples with 2% Alizarin Red S
for 5 min at room temperature to detect the osteoblastic
phenotype and identify any signs of mineralization. Chon-
drogenesis was confirmed by mucopolysaccharide staining
using Alcian Blue solution (1% alcian blue 8GX and 3%
glacial acetic acid, pH adjusted to 2.5). Adipogenic differ-
entiation was identified by Oil Red O staining (0.7 mg in
100 mL of propylene glycol) for 5 min at 60C. All these cell
differentiation assays were carried out at selected passages
(P1, P3, P6 and P9) to ascertain that HWJSCs retain their stem
cell nature throughout the ten cell passages.
Microarray analysis
Total RNA was isolated from three different samples
corresponding to three different individuals at each HWJSC
passage (P1 to P10) by using the Qiagen RNeasy System.
Total RNA was converted into cDNA using a reverse-
transcriptase (Superscript II, Life Technologies, Inc.) and T7-
oligo(dT) primer. Subsequently, biotinilated cRNA was
generated by using a T7 RNA polymerase and biotin-11-
uridine-5¢-triphosphate (Enzo Diagnostics). Labeled cRNA
were chemically fragmented to facilitate the hybridization
process and hybridized to Affymetrix Human Genome U133
plus 2.0 oligonucleotide arrays for 6 h at 45C. Finally, all
expression values were normalized using the software pro-
vided by Affymetrix to obtain comparable data and to identify
present (expressed) and absent (unexpressed) genes at each
cell passage. All expression data are publically available at
the public functional genomics data repository supporting
minimum information about a microarray experiment
(MIAME)-compliant data submissions GeneExpressionOmnibus
(www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30391).
Once expression levels were obtained for all probe sets, all
genes with apoptosis-related function were selected by using
the information supplied by Affymetrix. In addition, all MSC
markers proposed by the Mesenchymal and Tissue Stem Cell
Committee of the International Society for Cellular Ther-
apy32 were selected and analyzed at each cell passage
(CD105, CD73, CD90, CD11B, CD14, CD19, CD34, CD45,
CD79A, and HLADR) along with the cell proliferation
markers, proliferating cell nuclear antigen (PCNA) and MKI67.
Statistical analysis
The nonparametric Friedman test was used to evaluate
the statistical significance of differences among the 10 cell
passages analyzed. Pair-wise comparisons between two
successive cell subcultures were carried out using the non-
parametric Wilcoxon’s test. A Bonferroni-adjusted significance
level of £ 0.001 was considered for multiple comparisons,
because up to 48 statistical comparisons were performed
simultaneously using the Wilcoxon’s test. The Spearman
correlation test was used to establish correlations between
distributions corresponding to cell viability and cell prolif-
eration. The Statistical Package for the Social Sciences (SPSS)
16.00 software package was used for the statistical analysis.
In order to calculate average cell viability levels (ACVLs)
for each cell passage, the raw cell viability values determined
by trypan blue, WST-1, LIVE/DEAD, and K/Na index were
first normalized to z-scores (mean= 0 and standard devia-
tion = 1) using the formula: Z = (X -l)/r, where l is the av-
erage cell viability obtained for each method, X is the specific
cell viability for a particular cell passage, and r is the standard
deviation for each method. Then, mean z-scores values were
obtained for each of the 10 cell passages analyzed.
For the microarray analysis, we used the Pearson (r)
correlation test to determine the correlation between each
probe set and the ACVL for each cell passage. All genes
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with an absolute r correlation coefficient > 0.700 were se-
lected as being statistically significant. Gene Ontology (GO)
analysis of the selected genes was performed using BiNGO
(www.psb.ugent.be/cbd/papers/BiNGO/), a plug-in for
the Cytoscape program.33 The set of selected genes was
tested for enrichment of any GO category in comparison to
all annotated genes represented in the array. Scores were
evaluated based on the hypergeometric distribution and
using Bonferroni correction for multiple testing.34 To iden-
tify apoptosis-related genes whose expression was signifi-
cantly associated with the ACVL at the different cell
passages, we first selected all probe sets with a role in
apoptosis or anti-apoptosis by using the information pro-
vided by Affymetrix. These apoptosis-related genes were
then analyzed with version 3.09b of the significance anal-
ysis of microarrays (SAM) software of Stanford University,
using a d value that permitted a false discovery rate of 0
(i.e., no genes are falsely named). A multiclass analysis of
genes associated with the ACVLs was performed. The
program is available at www-stat.stanford.edu/*tibs/
SAM/.
Results
Culture and characterization of HWJSCs isolated
from human umbilical cord
Histological evaluation of HWJSC cultures from human
umbilical cord revealed that the cells were adherent and dis-
played a typical mesenchymal morphology, with spindle and
star-shaped cells. Specific conditioning media were used to
efficaciously differentiate the isolated HWJSCs in this study to
osteogenic, chondrogenic, and adipogenic cell lineages, as de-
termined by alizarin red S, alcian blue, and oil red O staining,
respectively, at all cell passages analyzed (P1, P3, P6, and P9).
Illustrative examples of the multi-lineage differentiation capa-
bility of HWJSCs at the first passage are shown in Figure 1.
Microarray analysis of specific MSC markers showed high
expression of CD105, CD73, and CD90 and no expression of
CD11B, CD14, CD19, CD34, CD45, CD79A, and HLADR at all
10 cell passages (P1 to P10; Table 1). Flow cytometry study
confirmed the high expression of CD90 and the absence of
CD45 expression in HWJSCs corresponding to the first, third,
sixth, and ninth cell passages (Fig. 2).
FIG. 1. Multi-lineage differentiation
capabilities of the cultured HWJSCs at cell
passage P1. (A) Undifferentiated control
HWJSCs (H&E staining). (B) HWJSCs
differentiated to the osteogenic cell type
showing positive calcium deposits by
alizarin red staining. (C) Differentiation
to the chondrogenic phenotype
(alcian blue staining). (D) Adipogenic
differentiation (oil red O). Scale bars:
50 mm. HWJSCs, Wharton’s jelly stem
cells. Color images available online at
www.liebertonline.com/tec
Table 1. mRNA Expression of Relevant MSC Markers as Determined by Microarray
in Wharton’s Jelly Stem Cells at Passages 1 to 10 (P1 to P10)
GENE P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
CD105 143.0 (P) 138.2 (P) 155.2 (P) 176.0 (P) 177.3 (P) 132.1 (P) 150.2 (P) 245.4 (P) 198.5 (P) 243.7 (P)
CD73 598.1 (P) 847.5 (P) 1052.5 (P) 1167.4 (P) 1205.9 (P) 892.3 (P) 1184.5 (P) 1519.1 (P) 1553.1 (P) 1785.2 (P)
CD90 2126.9 (P) 1438.8 (P) 1572.0 (P) 1783.5 (P) 1564.7 (P) 1416.3 (P) 2237.6 (P) 1874.2 (P) 1735.8 (P) 1732.5 (P)
CD11B 8.5 (A) 10.9 (A) 7.0 (A) 9.5 (A) 10.9 (A) 9.9 (A) 12.6 (A) 4.5 (A) 11.6 (A) 16.9 (A)
CD14 23.6 (A) 10.8 (A) 5.3 (A) 7.7 (A) 3.9 (A) 3.6 (A) 1.5 (A) 1.6 (A) 4.7 (A) 5.8 (A)
CD19 5.1 (A) 6.9 (A) 6.9 (A) 6.4 (A) 4.9 (A) 4.7 (A) 7.3 (A) 7.3 (A) 7.0 (A) 3.1 (A)
CD34 12.0 (A) 9.3 (A) 11.0 (A) 9.2 (A) 14.1 (A) 8.6 (A) 9.7 (A) 8.1 (A) 14.6 (A) 24.3 (A)
CD45 3.4 (A) 3.4 (A) 2.5 (A) 2.8 (A) 3.0 (A) 4.4 (A) 2.9 (A) 5.0 (A) 5.3 (A) 3.4 (A)
CD79A 28.5 (A) 33.7 (A) 22.7 (A) 38.2 (A) 29.0 (A) 31.5 (A) 38.2 (A) 23.5 (A) 25.7 (A) 24.2 (A)
HLADR 7.9 (A) 11.2 (A) 8.6 (A) 8.0 (A) 7.5 (A) 8.9 (A) 7.1 (A) 9.2 (A) 7.8 (A) 8.3 (A)
It shows the mean expression of each marker at each cell passage. A, absent gene expression; P, present gene expression (by Affymetrix
array).
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FIG. 2. Flow cytometry analysis of CD90 (positive MSC marker) and CD45 (negative MSC marker) in HWJSCs at passages
P1, P4, P6, and P9. Cells showing positive expression of each marker are shown in blue; green lines show the expression of
cells labeled with the control isotypes. Color images available online at www.liebertonline.com/tec
FIG. 3. Analysis of cell
proliferation and cell viability
of 10 successive passages of
HWJSC. (A) Cell proliferation
as determined by RTCA Real-
Time Cell Analysis Cell Index
(RTCA CI) and microarray
analysis of PCNA and MKI-
67. (B) Cell proliferation as
determined by electron-
probe X-ray microanalysis
(potassium/sodium index),
trypan blue exclusion
analysis, LIVE/DEAD Cell
Viability Assay, and WST-1.
(C) Average cell viability
level (ACVL). WST-1, water-
soluble tetrazolium salt-1.
Color images available online
at www.liebertonline
.com/tec
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Cell proliferation analysis of ten consecutive
cell passages of HWJSC
Microarray expression analysis of PCNA and MKI67 genes
showed no significant differences from the first to the tenth
cell passage (Fig. 3).
Application of highly sensitive RTCA revealed a highly
similar Cell Index in all 10 subcultures analyzed (Table 2 and
Fig. 3). According to the WST-1 assay results, the HWJSC
proliferation index tended to remain stable over the 10 cell
passages, with no statistically significant differences among
the passages (Table 2 and Fig. 3).
Sequential cell viability analysis of HWJSCs
Trypan blue staining showed that the cell viability of the
successive HWJSC subcultures was in general very high,
with > 82% viable cells at each of the 10 cell passages ana-
lyzed (Fig. 3 and Table 2). No significant differences were
observed among the different cell passages ( p> 0.001, Wil-
coxon test).
LIVE/DEAD Cell Viability Assay results showed a
nonsignificant decrease in the percentage of live cells from
the first to the third passage and a nonsignificant increase at
the fourth, with the percentage then remaining stable until
the ninth passage followed by a decrease to the tenth pas-
sage, when the lowest percentage of live cells was found (Fig.
3 and Table 2). Although statistical significance was not
reached, there was a tendency for these percentages to cor-
relate with the K/Na index of the cells as determined by
electron-probe X-ray microanalysis ( p= 0.0022 and r = 0.8428,
Spearman correlation test, for mean K/Na index values vs.
mean LIVE/DEAD Cell Viability) and with cell viability
and cell proliferation levels as determined by WST-1 assay
( p= 0.0117 and r= 0.7538, Spearman correlation test).
Microanalytical analysis of 10 consecutive HWJSC sub-
cultures showed generally high K/Na ratios for these stem
cells, ranging from 1.94 for the third cell passage to 6.40 for
the sixth passage (Table 3 and Fig. 4). The Friedman test for
multiple samples revealed significant differences ( p< 0.001)
among the 10 cell passages in the intracellular ionic con-
centration of all elements analyzed (Ca, Na, K, Mg, P, Cl, and
S; Table 4). Pairwise comparisons between consecutive cell
subcultures (Wilcoxon test) demonstrated a tendency for
several elements to increase or decrease their intracellular
concentrations with a higher number of passages. In-
tracellular K concentrations tended to decrease from the first
to the third passage, including a statistically significant dif-
ference between the second and the third passages, followed
by an increase until the seventh passage and then a statisti-
cally significant decrease to the eighth passage and a con-
tinuing decline to the tenth passage (Tables 3 and 4 and Fig.
4). In contrast, intracellular Na concentrations showed a
nonsignificant increase from the first to the second and third
passages, a decrease from the third to the fourth passage,
and an increase from the fifth to the seventh passage, de-
creasing thereafter (Tables 3 and 4 and Fig. 4). Intracellular
Cl concentrations significantly decreased from the first to the
second cell passage and from the sixth to the seventh pas-
sage and then significantly increased from the seventh to the
eighth passage. Intracellular P concentrations significantly
decreased from the first to the second cell passages and
from the seventh to the eighth passages. Intracellular Ca
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significantly decreased from the third to the fourth passage
and significantly increased from the seventh to the eighth
passage. Intracellular S significantly increased from the fifth
to the sixth passage and then significantly decreased from
the sixth to the seventh passages, and intracellular Mg sig-
nificantly increased from the seventh to the eighth passages.
Based on the results of the trypan blue, LIVE/DEAD,
WST-1, and electron-probe X-ray microanalysis assays, we
calculated the ACVL for each cell passage. As shown in
Figure 3, the highest ACVLs corresponded to the sixth and
fifth cell passages and the lowest to the eighth and tenth
passages.
Identification of genes associated with cell viability
at different cell passages
Correlation analysis of all genes in the array revealed
a significant positive correlation between ACVL and 630
probe sets and a significant negative correlation between
ACVL and 801 probe sets (data available on request). Func-
tional analysis of these genes (Table 5) showed an over-
representation of 10 gene functions among the 630 probe sets
positively correlated with cell viability, which were all re-
lated to the synthesis and maintenance of cell components
and cell structures (Table 5). No gene functions were over-
represented among the 801 probe sets negatively correlated
with ACVL.
SAM analysis of apoptosis-related genes revealed five
probe sets encoding for four different genes whose expres-
sion was significantly associated with ACVL (Fig. 5). Two of
these genes (FASTKD2 and BNIP3L) have been associated
with pro-apoptotic functions, and two (TNFAIP8 and
BCL2L2) have been associated with anti-apoptotic functions.
Discussion
MSCs derived from the human umbilical cord are being
considered a potential alternative source to bone marrow-
derived MSCs for cell therapy.4 HWJSCs are more readily
accessible and have a greater expansion potential in com-
parison to bone marrow-derived MSCs,35 which can only be
obtained after a painful and invasive procedure. Moreover, it
has been suggested that HWJSCs are immune privileged and
could, therefore, be tolerated in allogeneic transplantation.36
In this study, HWJSCs were found to fulfill all of the main
criteria for the use of human MSCs in cell therapy and tissue
FIG. 4. Histograms
representing the mean
intracellular concentrations
of potassium, sodium, and
chlorine and the K/Na ratio
for the ten consecutive
HWJSC passages (P1 to P10).
Statistically significant
changes (increases or
decreases) are indicated with
asterisks. Green bars corre-
spond to the control human
fibroblasts, while red bars
represent the same cells
treated with 10 mM HEMA
to induce apoptosis. All
measures are expressed as
millimoles per kilogram of
cell dry weight. Color images
available online at www
.liebertonline.com/tec
Table 4. Significance (P) Values for Differences in Intracellular Ionic Concentrations
of Calcium, Chlorine, Potassium, Magnesium, Sodium, Phosphorous, and Sulfur
Among Consecutive HWJSC Passages (P1 to P10)
Cell passages compared P1–P2 P2–P3 P3–P4 P4–P5 P5–P6 P6–P7 P7–P8 P8–P9 P9–P10 All (Friedman)
Ca 0.101 0.276 0.000a 0.602 0.117 0.248 0.000a 0.012 0.610 0.000a
Cl 0.001a 0.427 0.065 0.242 0.067 0.000a 0.000a 0.139 0.241 0.000a
K 0.211 0.001a 0.030 0.035 0.030 0.696 0.000a 0.284 0.878 0.000a
Mg 0.014 0.174 0.063 0.247 0.964 0.125 0.001a 0.575 0.414 0.000a
Na 0.830 0.545 0.006 0.607 0.192 0.012 0.970 0.386 0.047 0.000a
P 0.000a 0.253 0.062 0.135 0.304 0.840 0.000a 0.386 0.721 0.000a
S 0.788 0.187 0.326 0.022 0.000a 0.000a 0.035 0.169 0.959 0.000a
The nonparametric Wilcoxon test was used for pair-wise comparisons. The nonparametric Friedman test was used for global comparisons.
aStatistically significant p-values.
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engineering, including good proliferation rate in adherent
cell culture; high differentiation capability to osteogenic,
chondrogenic, and adipogenic cell lineages over multiple cell
passages; and, as previously reported,1 the expression of
several markers of undifferentiated MSC (CD105, CD103,
and CD90) and the nonexpression of CD45, among other
markers.32 These results confirm that the cultured cells were
HWJSCs and indicate that our cultured HWJSCs may be
clinically useful at the 10 cell passages analyzed.
A critical factor influencing the clinical outcomes of cell
therapy/transplantation procedures and the success of tissue
engineering is the viability and proliferative capacity of the
cells used.37–40 However, no fully sensitive and specific
method has yet been established that evaluates the cell via-
bility of human MSCs before their application in these con-
texts. It should also be taken into account that cell cultures
tend to age and lose viability after several passages in cul-
ture.10 Thus, evident morphological changes were recently
described in corneal endothelial cell cultures from the fourth
passage onward, with a trend for cell enlargement, cell
growth alterations, and a higher percentage of cell death
with increasing passage number.41 However, no data are
available on specific intracellular changes in HWJSCs kept in
culture for several passages, and little is known about the
influence of sequential subculturing on the cell viability and
proliferation capabilities of cultured HWJSCs.
In this study, we used classical (trypan blue exclusion) and
novel highly sensitive techniques (electron-probe X-ray mi-
croanalysis, calcein AM and ethidium homodimer-1, WST-1,
microarray, and RTCA) to determine cell viability and cell
proliferation. The highest ACVL was observed at the sixth
passage, although high cell viability levels were also found at
the first, fifth, and seventh passages. No significant change in
proliferative capability was observed at any of the 10 cell
passages analyzed. A high correlation was found among the
techniques used in this study, contrasting with the poor
correlation previously observed between trypan blue and
electron-probe X-ray microanalysis results for cell viability
levels in corneal endothelial cells9 and vascular endotheli-
um.10 The fact that HWJSCs are more undifferentiated than
adult endothelial cells and have a higher stemness potential
may account for this closer correlation.
Electron-probe X-ray microanalysis allows both qualita-
tive and quantitative determinations of the ionic elements
that play a role in cell viability. This approach permits the
accurate determination of cell viability and the identification
of mechanisms underlying the cell death found at given cell
Table 5. Cytoscape-BiNGO Functional Analysis
of Genes Showing a Significant Positive
Correlation (R > 0.7) With Average Cell Viability
Levels in Ten Consecutive HWJSC Passages,
as Determined by Microarray
GO-ID p-value
Corrected
p-value Gene functions
5739 3.13E-08 4.15E-05 Mitochondrion
5622 2.49E-05 1.65E-02 Intracellular
43231 5.26E-05 1.79E-02 Intracellular membrane-bound
organelle
43227 5.41E-05 1.79E-02 Membrane-bound organelle
313 9.16E-05 2.02E-02 Organellar ribosome
5761 9.16E-05 2.02E-02 Mitochondrial ribosome
44429 2.19E-04 3.47E-02 Mitochondrial part
314 2.36E-04 3.47E-02 Organellar small ribosomal
subunit
5763 2.36E-04 3.47E-02 Mitochondrial small ribosomal
subunit
44424 3.68E-04 4.89E-02 Intracellular part
GO-ID, gene ontology reference for each specific term or gene
function; p-value: statistical significance of the overrepresentation of
each GO term or gene function using a hypergeometric distribution;
Corrected p-value: statistical significance of the overrepresentation of
each GO term or gene function using a hypergeometric distribution
with Bonferroni correction for multiple testing; Gene functions: GO
terms identified by Cytoscape-BiNGO with a significant p-value.
FIG. 5. Significance Analysis of
Microarrays (SAM) results for all
genes with a role in apoptotic cell
death using multiclass analysis of
genes associated with the average
cell viability levels (ACVLs). All
differentially expressed probe sets
are represented in red color, and
their names are shown in the plot.
We used a d value that permitted
a false discovery rate of 0. Color
images available online at
www.liebertonline.com/tec
WHARTON’S JELLY CELL VIABILITY 9
passages.13–18 Although it is clear that most physiological cell
functions require a close control of intracellular levels of P, S,
Cl, Ca, and other ions, no data have been published on the
physiological concentrations of these elements in human
native umbilical cords or cultured HWJSCs.
According to the K/Na ratios observed in our study, the
highest cell viability levels were at the fifth and sixth pas-
sages, which also showed elevated cell proliferation rates.
Intracellular concentrations of Na and K are known to be
excellent markers of cell viability, and the K/Na ratio is one
of the most powerful microanalytical indicators of cell
damage.14,18,42 Decreased cell viability at the second, third,
and seventh passages may be apoptosis related, given the
significantly reduced intracellular levels of Cl in these sub-
cultures, whereas the decrease at passages 8, 9, and 10 may
be necrosis related, because elevated Cl concentrations were
found in the corresponding subcultures. The high Cl con-
centration at passage 1 may be associated with a necrosis-
related increase in mortality, which could result from the cell
isolation process and cell adaptation to the culture condi-
tions. A typical pattern of increased Na and depleted K and
Cl is well documented in cells undergoing death by apop-
tosis.19 Various authors have found an early decrease in K
and Cl to be an early predictor of apoptosis, reporting that
the decrease in Cl may be the more important of the two and
may be used to predict early cell damage.16 Hence, our
findings are compatible with reports on ionic changes in
preapoptotic cells and suggest that HWJSCs at the second,
third, and seventh passages should not be used for clinical
purposes because of the number undergoing cell death in the
corresponding subcultures. HWJSCs at the eighth, ninth, and
tenth passages also showed low viability levels and may not
be suitable for human cell therapy and tissue engineering.
Our analysis of the other major intracellular elements re-
vealed an initial decrease in Mg and P between the first and
the second cell passage that was statistically significant for P,
followed by a progressive increase in both elements until a
significant decrease after the seventh passage. According to
previous reports,9,43 these findings may be associated with
an initial reduction in the intracellular concentration of ATP
that would normalize over successive cell passages and then
decrease at passages 8, 9, and 10, when cells may be entering
senescence. Our observation of a significant increase in in-
tracellular S concentration at the sixth cell passage is con-
sistent with an increase in sulfated glycosaminoglycans at
this passage, when the cell viability is higher, confirming the
good functional status of HWJSCs in this subculture.44 In-
tracellular Ca levels were initially elevated but normalized
after the fourth cell passage, when a significant decrease in
Ca coincided with an increase in ACVL; Ca levels signifi-
cantly increased between the seventh and tenth passages,
when there was a decrease in ACVL. These results are con-
sistent with the known increase in intracellular Ca levels in
response to cell damage and apoptosis.45,46
We identified some of the genes that may be responsible
for the differences that have just been mentioned with regard
to cell viability among HWJSC passages. SAM analysis re-
sults demonstrated that the ACVL was significantly associ-
ated with four genes related to apoptotic activity. Two are
apoptosis-inhibitor genes, BCL2L2 and TNFAIP8, and the
latter has two different probe sets. BCL2L2 (GO:0006916:
anti-apoptosis and GO:0042981: regulation of apoptosis) is a
member of the BCL-2 apoptotic inhibitor gene family, whose
anti-apoptotic effects have been demonstrated in various
human cells and tumors.47 TNFAIP8 belongs to the tumor-
necrosis-factor gene family, which plays a role in the control
of cell viability and cell death (GO:0006916: anti-apoptosis,
GO:0006915: apoptosis, GO:0019987: negative regulation of
anti-apoptosis and GO:0043027: caspase inhibitor activity),
and the protein can be induced by TNF-a and other apo-
ptotic factors.48 The significant association of the expression
of these anti-apoptotic genes with cell viability may explain
some of the cell viability changes found in the first 10 con-
secutive passages of these cells. The combined action of these
genes may be responsible for the high cell viability found at
passages 5 and 6. The other two apoptosis-related genes
associated with the ACVL were the pro-apoptotic genes
BNIP3L and FASTKD2. The mitochondrial protein BNIP3L
(GO:0006917: induction of apoptosis and GO:0043066: neg-
ative regulation of apoptosis) is known to induce apoptosis
and cell growth arrest in transfected cells.49 Likewise,
FASTKD2 (GO:0006915: apoptosis) may play a role in the
regulation of mitochondrial apoptosis, given that FASTKD2
knockdown prevented apoptosis of breast cancer cells in an
ex vivo model of apoptosis.50 Taken together, all of the results
just mentioned suggest that a complex equilibrium of pro-
and anti-apoptotic gene signals may drive cell death and
senescence during sequential HWJSC subculture. These re-
sults are in agreement with electron-probe X-ray microanal-
ysis findings on the preapoptotic distribution of intracellular
elements in these cells.
Interestingly, all gene functions that were overrepresented
among the genes positively correlated with ACVL corre-
sponded to the synthesis and turnover of cellular compo-
nents. It appears that cells with the highest cell viability levels
(especially at fifth and sixth passages) activate multiple cell
processes associated with protein synthesis, cell growth, and
proliferation, although the differences in cell proliferation
among the 10 cell passages did not reach statistical signifi-
cance. The activation of these gene functions in cell passages
with high cell viability confirms the good metabolic status of
HWJSCs at these passages. It should be taken into account
that the cell viability may have been influenced by our study
conditions (e.g., trypsin concentration, cell confluence level,
etc.), and results may vary under different conditions.
In summary, these results support the utilization of the
highly sensitive methods described in this study for the
analysis of all cells selected for clinical purposes in order to
determine their vital status and ensure an adequate in vivo
survival rate. In general, our data indicate that the highest
cell viability levels correspond to the fifth and sixth HWJSC
passages, suggesting that these passages should be prefer-
entially used in cell therapy or tissue engineering protocols.
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